Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
Recruiting
Observational Study
Endometrial Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 45 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 25 (estimated)
- Sponsor
- Mayo Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Self-identified Black individuals ≥ 45 years with an intact uterus
* Assigned female sex at birth
* Experience with abnormal uterine or post-menopausal bleeding (defined as vaginal bleeding between periods, heavy vaginal bleeding, vaginal bleeding after menopause, and/or red, …
Contacts
Kelly Gunderson
507-422-1892
CONTACT